Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,044 AUD | 0,00% | -4,35% | -40,54% |
Vakgebied
Verkoop per activiteit
AUD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Radiopharmaceutical Products
100,0
%
| 0 | nan % | 0 | 100,0 % | - |
Verkoop per regio
AUD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Australia
100,0
%
| 0 | nan % | 0 | 100,0 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 13-09-21 | |
Antje Wegener
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gitasha Chand
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-22 |
Sherin Al-Safadi
CTO | Chief Tech/Sci/R&D Officer | - | 24-07-23 |
David Mozley
CTO | Chief Tech/Sci/R&D Officer | - | - |
Scot Harper
CTO | Chief Tech/Sci/R&D Officer | 67 | 01-12-21 |
Vittorio Puppo
COO | Chief Operating Officer | - | 01-06-22 |
Levente Meszaros
PRN | Corporate Officer/Principal | - | 01-01-22 |
Nathan Jong
SEC | Corporate Secretary | - | - |
Thomas Tulip
PRN | Corporate Officer/Principal | 71 | 01-09-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Paul Hopper
CHM | Chairman | 68 | 11-02-21 |
Leila Alland
BRD | Director/Board Member | 61 | 06-06-22 |
Chief Executive Officer | - | 13-09-21 | |
Ian Turner
BRD | Director/Board Member | - | - |
Hester Larkin
BRD | Director/Board Member | - | 03-02-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 371 639 096 | 274 806 210 ( 73,94 %) | 0 | 73,94 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Kwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-40,54% | 13,34 mln. | |
+34,00% | 664 mld. | |
+29,29% | 567 mld. | |
-7,75% | 354 mld. | |
+18,53% | 330 mld. | |
+4,95% | 286 mld. | |
+13,79% | 234 mld. | |
+4,93% | 199 mld. | |
-9,78% | 196 mld. | |
-4,89% | 148 mld. |